Results 151 to 160 of about 53,062 (221)
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses. [PDF]
Antimicrob Agents Chemother, 2018 Yoon JJ +20 more
europepmc +1 more source
Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 10, Issue S1, June 2026.
wiley +1 more source
Medical Journal of Australia, Volume 224, Issue 6, June 2026.ABSTRACT The 2025 NSW RSV Prevention Program, which achieved an estimated coverage of 63% maternal vaccination and 18% for infant immunisation, led to more than 40% reduction in RSV notifications and hospitalisations among infants aged younger than 6 months.
Janaki Amin +4 more
wiley +1 more source
The FASEB Journal, Volume 40, Issue 10, 31 May 2026.Inflammatory insults, such as sepsis, pneumonia, aspiration, or trauma can trigger an inflammatory reaction leading to Acute Respiratory Distress Syndrome (ARDS). This study identified that different causes lead to differences in n−3 and n−6 polyunsaturated fatty acids (PUFAs) and their downstream oxylipins.
Laura A. Leuenberger +11 more
wiley +1 more source
Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A(H1N1)pdm09 and human respiratory syncytial viruses. [PDF]
PLoS One, 2019 Cardoso AM +14 more
europepmc +1 more source
Age at First RSV Hospitalisation and the Risk of Subsequent Bacterial Pneumonia
Acta Paediatrica, Volume 115, Issue 6, Page 1298-1300, June 2026.
Samuel Videholm +4 more
wiley +1 more source
Respiratory co-infections between influenza viruses and respiratory syncytial virus (2014–2017)
Anales de Pediatría (English Edition), 2019 Jordi Reina, Joaquín Dueñas
openaire +3 more sources